Drug Price Trends for MICROGESTIN

Average Pharmacy Cost for MICROGESTIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
MICROGESTIN 21 1-20 TABLET	51862-0868-01	0.16611	EACH	2025-03-19
MICROGESTIN 21 1-20 TABLET	51862-0868-06	0.16611	EACH	2025-03-19
MICROGESTIN 21 1-20 TABLET	75907-0084-63	0.16611	EACH	2025-03-19
MICROGESTIN 21 1-20 TABLET	75907-0084-21	0.16611	EACH	2025-03-19

Market Analysis and Price Projections for Microgestin

Overview of Microgestin

Microgestin, a brand of oral contraceptive pills, falls under the broader category of contraceptive drugs. These pills, such as Microgestin Fe 1/20, contain a combination of ethinyl estradiol and norethindrone, and are widely used for birth control.

Global Contraceptive Drugs Market

The global contraceptive drugs market is experiencing significant growth, driven by several key factors:

• Market Size and Growth: The global contraceptive drugs market was valued at USD 18.57 billion in 2023 and is projected to grow to USD 37.22 billion by 2032, with a CAGR of 8.2% during the forecast period (2024-2032)[1][4].
• Regional Dominance: North America, particularly the U.S., dominates the market, with the U.S. contraceptive drugs market expected to reach USD 12.06 billion by 2032. However, the Asia Pacific region is anticipated to grow at the fastest pace due to increasing government initiatives and public awareness about family planning[1][4].

Product Segment Analysis

• Oral Contraceptives: The oral segment, which includes combined contraceptives and progestin-only pills, dominates the market with the highest market share. Oral contraceptives like Microgestin are preferred due to their ease of administration, affordability, and therapeutic benefits over other forms of contraception[1][4].

Distribution Channels

• Retail Pharmacy: The retail pharmacy segment accounts for the largest revenue share in the contraceptive drugs market. This is due to the increasing availability and accessibility of contraceptive pills through retail pharmacies, as well as growing public awareness of these products[4].

Pricing and Affordability

• Current Pricing: The cost for Microgestin Fe 1/20, for example, is around $55 for a supply of 168 tablets, depending on the pharmacy. This price is for cash-paying customers and does not include insurance plans[2].
• Discount Programs: There are various discount programs and cards available that can significantly reduce the cost of prescription medicines, including Microgestin. For instance, the Drugs.com Discount Card can save up to 80% on prescription medicines[2].

Generic Equivalents

• Generic Options: Many branded contraceptive drugs, including Microgestin, have generic equivalents available at significantly lower prices. Generics account for around 8 out of 10 prescriptions, making them a cost-effective alternative[3].

Market Drivers

• Government Initiatives: Increasing government initiatives to expand access to contraceptive drugs and public programs aimed at creating awareness about birth control are key drivers of the market[1][4].
• Insurance Coverage: Growing insurance coverage and the introduction of over-the-counter (OTC) contraceptive products also contribute to the market's growth[1].

Competitive Landscape

• Top Market Players: Companies like Johnson & Johnson Services, Inc., AbbVie Inc., and Bayer AG are major players in the contraceptive drugs market. These companies focus on strategic collaborations and the development of new products to gain a competitive advantage[1].

Future Projections

• CAGR and Market Size: The global contraceptive drugs market is expected to grow at a CAGR of 8.2% from 2024 to 2032, reaching USD 37.22 billion by 2032. This growth is driven by increasing demand, especially in the Asia Pacific region, and the introduction of new products[1][4].

Key Takeaways

• The global contraceptive drugs market, including Microgestin, is poised for significant growth driven by increasing awareness, government initiatives, and the availability of affordable options.
• The oral segment, particularly combined contraceptives and progestin-only pills, will continue to dominate the market.
• Retail pharmacies will remain a major distribution channel.
• Generic equivalents will continue to offer cost-effective alternatives.
• North America will maintain its market dominance, while the Asia Pacific region will experience the fastest growth.

FAQs

1. What is the current market size of the global contraceptive drugs market?

   • The global contraceptive drugs market was valued at USD 18.57 billion in 2023[1].

2. What is the projected growth rate of the global contraceptive drugs market?

   • The market is expected to grow at a CAGR of 8.2% from 2024 to 2032[1].

3. Which segment dominates the contraceptive drugs market?

   • The oral segment, including combined contraceptives and progestin-only pills, dominates the market[1][4].

4. How much does Microgestin Fe 1/20 typically cost?

   • The cost for Microgestin Fe 1/20 is around $55 for a supply of 168 tablets, depending on the pharmacy[2].

5. Are there any discount programs available for Microgestin?

   • Yes, there are discount programs like the Drugs.com Discount Card that can save up to 80% on prescription medicines, including Microgestin[2].

Sources

1. Fortune Business Insights - Contraceptive Drugs Market Size, Share | Global Report, 2032
2. Drugs.com - Microgestin Fe 1/20 Prices, Coupons, Copay Cards & Patient Assistance
3. RxSpark - MICROGESTIN 24 FE Drug Info
4. GlobeNewswire - Global Contraceptive Drugs Market Size To Worth USD 40.08 Billion By 2033-CAGR Of 8.02%